Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
1.750
-0.110 (-5.91%)
At close: Nov 19, 2026, 4:00 PM EST
1.720
-0.030 (-1.71%)
After-hours: Nov 19, 2026, 4:10 PM EST
Jyong Biotech Market Cap
Jyong Biotech has a market cap or net worth of $129.91 million as of November 19, 2026. It is the 22,879th most valuable company in the world and the 3,812th biggest in the United States. Its market cap has decreased by 94.34% in one year.
Market Cap
129.91M
Enterprise Value
147.28M
1-Year Change
-94.34%
Global Rank
Country Rank
#3,812 United States
Category
ChartMarket Cap Chart
Since June 17, 2025, Jyong Biotech's market cap has decreased from $777.46M to $129.91M, a decrease of -83.29%. That is a compound annual growth rate of -71.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 129.91M | -57.23% |
| Dec 31, 2025 | 303.76M | -60.93% |
| Jun 17, 2025 | 777.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 138.70M |
| MacroGenics | 138.68M |
| Fate Therapeutics | 138.59M |
| ALX Oncology Holdings | 138.28M |
| Satellos Bioscience | 136.27M |
| Canton Strategic Holdings | 133.02M |
| Yarrow Bioscience | 129.61M |
| Innate Pharma | 127.48M |